Related references
Note: Only part of the references are listed.Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Laurie A. Lee et al.
LANCET RESPIRATORY MEDICINE (2021)
Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: A population-based observational study
Chloe Bloom et al.
PLOS MEDICINE (2020)
Inhaled Corticosteroid Therapy in Adult Asthma Time for a New Therapeutic Dose Terminology
Richard Beasley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 μG Versus Twice-Daily Fluticasone Propionate 250 μG in Adolescents and Adults with Persistent Asthma
Ryan Tomlinson et al.
LUNG (2017)
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Peter T. Daley-Yates
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Epidemiology and economic burden of asthma
Patricia A. Loftus et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2015)
Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial
W. W. Busse et al.
ALLERGY (2014)
Changes to inhaled corticosteroid dose when initiating combination inhaler therapy in long-acting β agonist-naive patients with asthma: a retrospective database analysis
Jordan R. Covvey et al.
THORAX (2014)
Fluticasone Furoate-Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial
Eugene R. Bleecker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development
I. Demin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Standardized Visual Predictive Check Versus Visual Predictive Check for Model Evaluation
Diane D. Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Model-Based Meta-Analysis for Comparative Efficacy and Safety: Application in Drug Development and Beyond
J. W. Mandema et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells
Christos Rossios et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships
Philippa Delahoy et al.
BMC NEUROLOGY (2010)
Challenges of treating asthma in people who smoke
Mark Spears et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma
Wendy Gould et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease
Mark Salter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Summing up 100 years of asthma
Zuzana Diamant et al.
RESPIRATORY MEDICINE (2007)
Eosinophilic bronchitis in asthma: A model for establishing dose-response and relative potency of inhaled corticosteroids
Margaret M. Kelly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Share Paper
